Vancomycin plus imipenem, ceftazidime or ciprofloxacin in second line therapy in patients with febrile neutropenia not responding to first line therapy
Dive into the research topics of 'Vancomycin plus imipenem, ceftazidime or ciprofloxacin in second line therapy in patients with febrile neutropenia not responding to first line therapy'. Together they form a unique fingerprint.